Videos

Bridget Shields, MD, medical dermatology fellow at the University of Pennsylvania School of Medicine, discusses common skin manifestations of inflammatory bowel disease, treatment options that target the skin and gut, and the importance of co-managing this disease across specialties.

Jeffrey Sparks, MD, gives a summary of his talk on the pulmonary manifestations of rheumatic diseases, which he presented at the virtual Interdisciplinary Autoimmune Summit held July 10-12.

In this video, Jessica Allegretti, MD, provides a preview of her presentation on the evolving role of fecal microbiota transplantation in treating immune-mediated inflammatory diseases which she will give at IAS 2020 Virtual.

In this video, Bridget Shields, MD, medical dermatology fellow at the University of Pennsylvania School of Medicine, shares what she is looking forward to about this year's Interdisciplinary Autoimmune Summit virtual meeting and why health care practitioners who treat autoimmune diseases should attend.

In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy.

In this video, Walter Koltun, MD, from Penn State Health, discusses what gastroenterologists should be telling their patients about the expected outcomes of ileal pouch–anal anastomosis.

In this video, Jeffrey R. Curtis, MD, MPH, discusses the importance of vaccinations among individuals with immune-mediated inflammatory diseases, the potential for poor outcomes if patients do not follow a vaccination schedule, and more.

In this video, Dr Rubin, from the University of Chicago, discusses the challenges in the management of dysplasia and preventing cancer in patients with ulcerative colitis.

In this video, Dr Rubin, from the University of Chicago, discusses the importance of screening and surveillance for dysplasia and colorectal cancer among patients with inflammatory bowel disease, and more.

In this video, Vibeke Strand, MD, discusses immunogenicity and its contributing factors among individuals with immune-mediated inflammatory diseases.